Pfizer-BioNTech submit data to U.S. FDA for COVID-19 vaccine in younger children
CBC
Pfizer Inc. and BioNTech SE submitted initial trial data for their COVID-19 vaccine in children aged 5 to 11 to U.S. regulators on Tuesday and said they would make a formal request for emergency use authorization in the coming weeks.
Coronavirus infections have soared in children and hit their highest point in early September, according to data from the American Academy of Pediatrics.
The vaccine, which is already authorized in teens aged 12 to 15 and fully approved for ages 16 and up in the U.S., has been shown to induce a strong immune response in the target age group in a 2,268-participant clinical trial, the companies said on Sept. 20.
The Pfizer-BioNTech vaccine was authorized in kids aged 12-15 roughly a month after the companies filed for authorization. If the same timeline is followed for this application, kids could start receiving their shots as soon as late October.
A rapid authorization could help mitigate a potential surge of cases this fall, with schools already open nationwide.
While kids are less susceptible to severe COVID-19, they can spread the virus to others, including vulnerable populations that are more at risk of severe illness.
Researchers say there's been a dramatic rise in the number of people going on medications to treat attention deficit/hyperactivity disorder in Ontario, suggesting factors such as more time spent online and the rise of private assessments for the mental condition could be behind the increase.
Baby, it’s cold outside — but it’s worth putting on that heavy winter coat, scarf and boots and heading out for one of the best meteor showers of the year: the Geminids.
Health officials are reminding Canadians to maintain healthy habits during the holiday season, as influenza leads to more school absences and hospitalizations.
For 40 years, staff at Nova Scotia's Annapolis Royal Historic Gardens thought their ginkgo tree was male.
Health Canada has authorized a new drug to treat postpartum depression.
A website selling moccasins with what looks like Haudenosaunee-style beadwork but with no attribution to an artist or community has sparked conversation online about how to identify authentic Indigenous crafts.
More Canadians have a family doctor or nurse practitioner compared with three years ago, but satisfaction remains low, a comprehensive new survey suggests.
This could be an unusually good year to spot snowy owls in southern Canada.
Over five dozen items belonging to First Nations, Inuit, and Métis are one step closer to returning home.
After Canada announced Tuesday it wouldn’t list the American eel under the Species at Risk Act (SARA) some First Nations people with cultural and spiritual ties to the species are questioning the decision.
The B.C. government is issuing new guidance for physicians when it comes to treating youth with overlapping cases of mental health and substance use challenges, clarifying the use of involuntary care in the process.
Former Assembly of First Nations national chief RoseAnne Archibald says her lawsuit against the national advocacy organization is moving forward, after settlement talks “were stalled and stonewalled” for 18 months.
An early start to Canada’s flu season is hitting children hard, sending a flood of young patients into multiple pediatric hospitals as medical teams warn that emergency visits and admissions could keep climbing in the weeks ahead.